PA-8 Catalog No.:M27505-C InChi: InChI=1S/C14H16ClNO/c15-9-4-3-5-10(8-9)16-14(17)13-11-6-1-2-7-12(11)13/h3-5

InChi: InChI=1S/C14H16ClNO/c15-9-4-3-5-10(8-9)16-14(17)13-11-6-1-2-7-12(11)13/h3-5

57(22):10645-50

is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity

Y27632 promotes neuronal differentiation of adipose tissue-derived stem cells (ADSCs)

InChiKey: PETUTZMMIOWORO-RALIUCGRSA-N

PA-8 Catalog No.:M27505-C InChi: InChI=1S/C14H16ClNO/c15-9-4-3-5-10(8-9)16-14(17)13-11-6-1-2-7-12(11)13/h3-5PA 8 is a potent, selective and orally active PACAP type I (PAC1) receptor antagonist. PA 8 inhibits the phosphorylation of CREB induced by PACAP in PAC1 , but not VPAC1 or VPAC2 receptor. PA 8 also inhibits PACAP induced cAMP elevation with an IC50 of 2 nM. Product information CAS Number: 878437 15 1 Molecular Weight: 342. 35 Formula: C17H18N4O4 Chemical Name: 2 amino 5 [3 methoxy 4 (prop 2 en 1 yloxy)phenyl] 3H,4H,5H,6H,7H,8H pyrido[2,3 d]pyrimidine